BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 7606004)

  • 21. The commonly deleted region at 9p21-22 in lymphoblastic leukemias spans at least 400 kb and includes p16 but not p15 or the IFN gene cluster.
    Aguiar RC; Sill H; Goldman JM; Cross NC
    Leukemia; 1997 Feb; 11(2):233-8. PubMed ID: 9009086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
    Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
    J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia.
    Cayuela JM; Madani A; Sanhes L; Stern MH; Sigaux F
    Blood; 1996 Mar; 87(6):2180-6. PubMed ID: 8630377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias.
    Nakamaki T; Kawamata N; Schwaller J; Tobler A; Fey M; Pakkala S; Lee YY; Kim BK; Fukuchi K; Tsuruoka N
    Br J Haematol; 1995 Sep; 91(1):139-49. PubMed ID: 7577621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular analysis of cyclin-dependent kinase inhibitors in human leukemias.
    Hayette S; Thomas X; Bertrand Y; Tigaud I; Callanan M; Thiebaut A; Charrin C; Archimbaud E; Magaud JP; Rimokh R
    Leukemia; 1997 Oct; 11(10):1696-9. PubMed ID: 9324291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
    Batova A; Diccianni MB; Yu JC; Nobori T; Link MP; Pullen J; Yu AL
    Cancer Res; 1997 Mar; 57(5):832-6. PubMed ID: 9041181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of cyclin-dependent kinase inhibitor genes and development of human acute leukemias.
    Ragione FD; Iolascon A
    Leuk Lymphoma; 1997 Mar; 25(1-2):23-35. PubMed ID: 9130611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.
    Tahara H; Smith AP; Gaz RD; Arnold A
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia.
    Iravani M; Dhat R; Price CM
    Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of ETV6 (TEL) gene rearrangements or p16INK4A/p15INK4B homozygous gene deletions in infant acute lymphoblastic leukemia.
    Maloney KW; Rubnitz JE; Cleary ML; Frankel LS; Hakami N; Link MP; Pullen DJ; Hunger SP
    Leukemia; 1997 Jul; 11(7):979-83. PubMed ID: 9204978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aneuploidy of chromosome 9 and the tumor suppressor genes p16(INK4) and p15(INK4B) detected by in situ hybridization in locally advanced prostate cancer.
    Heidenreich B; Heidenreich A; Sesterhenn A; Srivastava S; Moul JW; Sesterhenn IA
    Eur Urol; 2000 Oct; 38(4):475-82. PubMed ID: 11025389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of the p53, p21, p16, p15 and RAS genes in childhood T-cell acute lymphoblastic leukemia.
    Kawamura M; Ohnishi H; Guo SX; Sheng XM; Minegishi M; Hanada R; Horibe K; Hongo T; Kaneko Y; Bessho F; Yanagisawa M; Sekiya T; Hayashi Y
    Leuk Res; 1999 Feb; 23(2):115-26. PubMed ID: 10071127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of cyclin-dependent kinase inhibitor genes and chromosome 9 karyotypic abnormalities in human bladder cancer cell lines.
    Southgate J; Proffitt J; Roberts P; Smith B; Selby P
    Br J Cancer; 1995 Nov; 72(5):1214-8. PubMed ID: 7577470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of the Hel-N1 gene in childhood acute lymphoblastic leukemia with LOH at 9p21.
    Takeuchi C; Takeuchi S; Ikezoe T; Bartram CR; Koeffler HP; Taguchi H
    Leukemia; 1999 Apr; 13(4):650-1. PubMed ID: 10214879
    [No Abstract]   [Full Text] [Related]  

  • 35. Intragenic mutations of the p16(INK4), p15(INK4B) and p18 genes in primary non-small-cell lung cancers.
    Rusin MR; Okamoto A; Chorazy M; Czyzewski K; Harasim J; Spillare EA; Hagiwara K; Hussain SP; Xiong Y; Demetrick DJ; Harris CC
    Int J Cancer; 1996 Mar; 65(6):734-9. PubMed ID: 8631583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
    Faderl S; Estrov Z; Kantarjian HM; Thomas D; Cortes J; Manshouri T; Chan CC; Hays KJ; Pierce S; Albitar M
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):159-63. PubMed ID: 10641574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel pre-B acute lymphoblastic leukemia cell line with chromosomal translocation between p16(INK4A)/p15(INK4B) tumor suppressor and immunoglobulin heavy chain genes: TGFbeta/IL-7 inhibitory signaling mechanism.
    Urashima M; Hoshi Y; Sugimoto Y; Kaihara C; Matsuzaki M; Chauhan D; Ogata A; Teoh G; DeCaprio JA; Anderson KC
    Leukemia; 1996 Oct; 10(10):1576-83. PubMed ID: 8847892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
    Guan KL; Jenkins CW; Li Y; Nichols MA; Wu X; O'Keefe CL; Matera AG; Xiong Y
    Genes Dev; 1994 Dec; 8(24):2939-52. PubMed ID: 8001816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of the INK4A and INK4B gene loci in human breast cancer cell lines and primary carcinomas.
    Bisogna M; Calvano JE; Ho GH; Orlow I; Cordón-Cardó C; Borgen PI; Van Zee KJ
    Cancer Genet Cytogenet; 2001 Mar; 125(2):131-8. PubMed ID: 11369056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent codeletion of p16/MTS1 and p15/MTS2 and genetic alterations in p16/MTS1 in pancreatic tumors.
    Naumann M; Savitskaia N; Eilert C; Schramm A; Kalthoff H; Schmiegel W
    Gastroenterology; 1996 Apr; 110(4):1215-24. PubMed ID: 8613012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.